FILZEPH Trademark

Trademark Overview


On Wednesday, May 24, 2023, a trademark application was filed for FILZEPH with the United States Patent and Trademark Office. The USPTO has given the FILZEPH trademark a serial number of 98010526. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, June 11, 2024. This trademark is owned by Glaxo Group Limited. The FILZEPH trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders
filzeph

General Information


Serial Number98010526
Word MarkFILZEPH
Filing DateWednesday, May 24, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, June 11, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 16, 2024

Trademark Statements


Goods and ServicesVaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, June 14, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB

Trademark Events


Event DateEvent Description
Saturday, May 27, 2023NEW APPLICATION ENTERED
Wednesday, June 14, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, July 12, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, July 12, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, July 12, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 9, 2024ASSIGNED TO EXAMINER
Monday, January 22, 2024NON-FINAL ACTION WRITTEN
Monday, January 22, 2024NON-FINAL ACTION E-MAILED
Monday, January 22, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 8, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 8, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 8, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 11, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 27, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 16, 2024PUBLISHED FOR OPPOSITION
Tuesday, April 16, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 11, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, November 7, 2024TEAS DELETE 1(B) BASIS RECEIVED